BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15813703)

  • 1. The N domain of somatic angiotensin-converting enzyme negatively regulates ectodomain shedding and catalytic activity.
    Woodman ZL; Schwager SL; Redelinghuys P; Carmona AK; Ehlers MR; Sturrock ED
    Biochem J; 2005 Aug; 389(Pt 3):739-44. PubMed ID: 15813703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homologous substitution of ACE C-domain regions with N-domain sequences: effect on processing, shedding, and catalytic properties.
    Woodman ZL; Schwager SL; Redelinghuys P; Chubb AJ; van der Merwe EL; Ehlers MR; Sturrock ED
    Biol Chem; 2006 Aug; 387(8):1043-51. PubMed ID: 16895474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shedding of somatic angiotensin-converting enzyme (ACE) is inefficient compared with testis ACE despite cleavage at identical stalk sites.
    Woodman ZL; Oppong SY; Cook S; Hooper NM; Schwager SL; Brandt WF; Ehlers MR; Sturrock ED
    Biochem J; 2000 May; 347 Pt 3(Pt 3):711-8. PubMed ID: 10769174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design.
    Corradi HR; Schwager SL; Nchinda AT; Sturrock ED; Acharya KR
    J Mol Biol; 2006 Mar; 357(3):964-74. PubMed ID: 16476442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function discrimination of the N- and C- catalytic domains of human angiotensin-converting enzyme: implications for Cl- activation and peptide hydrolysis mechanisms.
    Tzakos AG; Galanis AS; Spyroulias GA; Cordopatis P; Manessi-Zoupa E; Gerothanassis IP
    Protein Eng; 2003 Dec; 16(12):993-1003. PubMed ID: 14983080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory antibodies to human angiotensin-converting enzyme: fine epitope mapping and mechanism of action.
    Skirgello OE; Balyasnikova IV; Binevski PV; Sun ZL; Baskin II; Palyulin VA; Nesterovitch AB; Albrecht RF; Kost OA; Danilov SM
    Biochemistry; 2006 Apr; 45(15):4831-47. PubMed ID: 16605251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of structural motifs on the ectodomain shedding of human angiotensin-converting enzyme.
    Conrad N; Schwager SL; Carmona AK; Sturrock ED
    Biochem Biophys Res Commun; 2016 Dec; 481(1-2):111-116. PubMed ID: 27818199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine epitope mapping of monoclonal antibodies 9B9 and 3G8 to the N domain of angiotensin-converting enzyme (CD143) defines a region involved in regulating angiotensin-converting enzyme dimerization and shedding.
    Gordon K; Balyasnikova IV; Nesterovitch AB; Schwartz DE; Sturrock ED; Danilov SM
    Tissue Antigens; 2010 Feb; 75(2):136-50. PubMed ID: 20003136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phorbol ester-induced juxtamembrane cleavage of angiotensin-converting enzyme is not inhibited by a stalk containing intrachain disulfides.
    Schwager SL; Chubb AJ; Scholle RR; Brandt WF; Eckerskorn C; Sturrock ED; Ehlers MR
    Biochemistry; 1998 Nov; 37(44):15449-56. PubMed ID: 9799507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope-dependent blocking of the angiotensin-converting enzyme dimerization by monoclonal antibodies to the N-terminal domain of ACE: possible link of ACE dimerization and shedding from the cell surface.
    Kost OA; Balyasnikova IV; Chemodanova EE; Nikolskaya II; Albrecht RF; Danilov SM
    Biochemistry; 2003 Jun; 42(23):6965-76. PubMed ID: 12795591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides for defining substrate specificity of the angiotensin I-converting enzyme and development of selective C-domain substrates.
    Bersanetti PA; Andrade MC; Casarini DE; Juliano MA; Nchinda AT; Sturrock ED; Juliano L; Carmona AK
    Biochemistry; 2004 Dec; 43(50):15729-36. PubMed ID: 15595828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulated interactions between angiotensin-converting enzyme and substrate gonadotropin-releasing hormone: novel insights into domain selectivity.
    Papakyriakou A; Spyroulias GA; Sturrock ED; Manessi-Zoupa E; Cordopatis P
    Biochemistry; 2007 Jul; 46(30):8753-65. PubMed ID: 17605472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic release of membrane-bound angiotensin-converting enzyme: role of the juxtamembrane stalk sequence.
    Ehlers MR; Schwager SL; Scholle RR; Manji GA; Brandt WF; Riordan JF
    Biochemistry; 1996 Jul; 35(29):9549-59. PubMed ID: 8755736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of juxtamembrane cleavage ("shedding") of angiotensin-converting enzyme by stalk glycosylation: evidence for an alternative shedding protease.
    Schwager SL; Chubb AJ; Scholle RR; Brandt WF; Mentele R; Riordan JF; Sturrock ED; Ehlers MR
    Biochemistry; 1999 Aug; 38(32):10388-97. PubMed ID: 10441133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined use of selective inhibitors and fluorogenic substrates to study the specificity of somatic wild-type angiotensin-converting enzyme.
    Jullien ND; Cuniasse P; Georgiadis D; Yiotakis A; Dive V
    FEBS J; 2006 Apr; 273(8):1772-81. PubMed ID: 16623712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain.
    Georgiadis D; Cuniasse P; Cotton J; Yiotakis A; Dive V
    Biochemistry; 2004 Jun; 43(25):8048-54. PubMed ID: 15209500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ectodomain shedding of angiotensin-converting enzyme is independent of its localisation in lipid rafts.
    Parkin ET; Tan F; Skidgel RA; Turner AJ; Hooper NM
    J Cell Sci; 2003 Aug; 116(Pt 15):3079-87. PubMed ID: 12799421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic probes for inter-domain co-operation in human somatic angiotensin-converting enzyme.
    Skirgello OE; Binevski PV; Pozdnev VF; Kost OA
    Biochem J; 2005 Nov; 391(Pt 3):641-7. PubMed ID: 16033330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of domain-selective angiotensin I-converting enzyme inhibitors.
    Redelinghuys P; Nchinda AT; Sturrock ED
    Ann N Y Acad Sci; 2005 Nov; 1056():160-75. PubMed ID: 16387685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of a lipophilic captopril analogue binding to angiotensin I converting enzyme.
    Dalkas GA; Marchand D; Galleyrand JC; Martinez J; Spyroulias GA; Cordopatis P; Cavelier F
    J Pept Sci; 2010 Feb; 16(2):91-7. PubMed ID: 20014331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.